What are the possible complications of percutaneous transcatheter treatment for deep venous thrombosis (DVT)?

Updated: Dec 10, 2019
  • Author: Donald Schreiber, MD, CM; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print
Answer

Answer

The hemorrhagic complications of thrombolytic therapy are formidable (approximately 3 times higher than that of anticoagulant therapy) and include the small, but potentially fatal, risk of intracerebral hemorrhage. The uncertainty regarding thrombolytic therapy is likely to continue. The American College of Chest Physicians (ACCP) 2008 consensus guidelines recommend catheter-directed thrombolytic therapy only for selected patients with extensive acute proximal DVT (eg, those with iliofemoral DVT, symptoms for less than 14 days, good functional status, and life expectancy of >1 year) who are at low risk of bleeding. [14]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!